Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial

  title={Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial},
  author={Giles J. Peek and Miranda Mugford and Ravindranath Tiruvoipati and Andrew Wilson and Elizabeth M Allen and Mariamma M Thalanany and Clare L. Hibbert and Ann Truesdale and Felicity Clemens and Nicola J Cooper and Richard K. Firmin and Diana Elbourne},
  journal={The Lancet},

Figures and Tables from this paper

Venovenous extracorporeal membrane oxygenation versus conventional mechanical ventilation to treat refractory hypoxemia in patients with acute respiratory distress syndrome: a retrospective cohort study
Although VV-ECMO promoted lower-TV ventilation, it did not improve the in-hospital mortality rate and was not significantly different between the two groups.
Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study
Age, severity of hypoxaemia, and duration and intensity of mechanical ventilation were found to be modifiers of treatment effectiveness and should be considered when deciding to initiate ECMO in patients with covid-19.
Trends in and perspectives on extracorporeal membrane oxygenation for severe adult respiratory failure
Clinical usefulness of ECMO was documented in many cases of severe ARDS secondary to influenza A (H1N1) 2009 infection, and ECMO can be expected to gain importance as a respiratory support technique.
Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort
Ultraprotective lung ventilation on ECMO was largely adopted across medium- to high-case volume ECMO centers and did not impact patients' prognosis in this context.
ECMO in adults for severe respiratory failure finally comes of age: just in time?
A randomised controlled trial of conventional ventilation or ECMO in patients with severe ARF (CESAR), the results of which have just been reported.
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome in adult patients: a systematic review and meta-analysis
Respiratory ECMO support in severe acute respiratory distress syndrome patients is associated with a reduced mortality rate and a reduced need for renal replacement therapy but a substantial increase in the lengths of stay in the intensive care unit and hospital.
Present and Future of ECMO in ICU
The common terminologies used with ECMO, the practical running mode of EC MO, indications of ECMO application in intensive care unit settings and results of recent clinical trials are reported.
A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study.
The use of HFOV had no effect on 30-day mortality in adult patients undergoing mechanical ventilation for ARDS and no economic advantage, and it is suggested that further research into avoiding ventilator-induced lung injury should concentrate on ventilatory strategies other than HFOv.
Does Extracorporeal Membrane Oxygenation Improve Survival in Pediatric Acute Respiratory Failure?
In children with severe ARDS, the results do not demonstrate that ECMO‐ supported children have superior outcomes compared with non‐ECMO‐supported children, and definitive answers will require a rigorous multisite randomized controlled trial.


Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR).
Compared with CM, transferring adult patients with severe but potentially reversible respiratory failure to a single centre specialising in the treatment of severe respiratory failure for consideration of ECMO significantly increased survival without severe disability.
CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure
This randomised controlled trial is to assess whether extracorporeal membrane oxygenation will increase the rate of survival without severe disability by six months post-randomisation, and be cost effective from the viewpoints of the NHS and society, compared to conventional ventilatory support.
Extracorporeal membrane oxygenation for adult respiratory failure.
Survival with ECMO is 66% for adults with severe respiratory failure, and ECMO should be considered in patients who remain hypoxic despite maximal positive pressure ventilation.
Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome.
It is concluded that there was no significant difference in survival between the mechanical ventilation and the extracorporeal CO2 removal groups, and extracordoreal support for ARDS should be restricted to controlled clinical trials.
The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: follow-up to 1 year of age.
  • Medicine
  • 1998
The results are in accord with the earlier preliminary findings that a policy of ECMO support reduces the risk of death without a concomitant rise in severe disability.
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study.
It is concluded that ECMO can support respiratory gas exchange but did not increase the probability of long-term survival in patients with severe ARF.
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study.
Thirty-nine newborn infants with severe persistent pulmonary hypertension and respiratory failure who met criteria for 85% likelihood of dying were enrolled in a randomized trial in which
A multicenter trial of prolonged prone ventilation in severe acute respiratory distress syndrome.
Pone ventilation is feasible and safe, and may reduce mortality in patients with severe ARDS when it is initiated early and applied for most of the day.
Extracorporeal life support for 100 adult patients with severe respiratory failure.
Modeling of variables during ECLS showed that no mechanical complications were independent predictors of outcome, and the only patient-related complications associated with outcome were the presence of renal failure and significant surgical site bleeding.